NIH-funded research Fellowship grant

Investigating how H2AJ affects placental aging and structure

Official title: H2AJ as a regulator of placental senescence and genome organization

Funded at Yale University · NIH-11058454 · Data updated 2026-11-12

This study is looking at how a special protein called H2AJ affects the growth and aging of the placenta, especially in pregnancy issues like pre-eclampsia, to help find new ways to improve pregnancy health.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startApril 16, 2023
Project endApril 15, 2027
Funding year2025
Award (this year)$53,974
NIH project number5F30HD112087-03
Project IDNIH-11058454 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals, particularly those in their first or third trimester, who may be at risk for pre-eclampsia.

Less likely to help

Patients who are not pregnant or those who do not have a history of placental dysfunction may not benefit from this research.

What this research studies

This research explores the role of a specific histone variant, H2AJ, in the development and aging of the placenta. By studying human embryonic stem cells, the researchers aim to understand how H2AJ influences trophoblast differentiation and the organization of the genome. The project focuses on the senescence-associated secretory phenotype (SASP) in placental dysfunction, particularly in conditions like pre-eclampsia. The findings could lead to new therapeutic strategies targeting these mechanisms to improve pregnancy outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for pre-eclampsia, potentially improving maternal and fetal health.

How similar studies have gone: Other research has shown promise in targeting senescence in placental dysfunction, suggesting that this approach could yield significant insights.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Jensen, Tyler Barry — Yale University
  • Study coordinator: Jensen, Tyler Barry

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.